Are There New MPN Therapies in Development to Decrease Fibrosis?

Description: “Can we interrupt the fibrotic process?” MPN expert Dr. Srdan Verstovsek of MD Anderson Cancer Center explains PRM-151, and how this anti-fibrotic therapy is being used to improve the quality of life for patients living with a myeloproliferative neoplasm (MPN). Dr. Verstovsek ends this conversation with these words, “With good control….it appears to be making people live longer.”

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube |
Like on Facebook |
Follow on Twitter |
Follow on Google+ |
Shared By : P2Professional
Posted on : 02/09/16
Added : 3 years ago